- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- December 2024
Global
From €6826EUR$7,500USD£5,798GBP
- Report
- May 2021
- 97 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- June 2022
- 150 Pages
Global
From €2202EUR$2,419USD£1,870GBP
€3146EUR$3,456USD£2,672GBP
Topical Oxygen Therapy (TOT) is a type of respiratory device used to treat hypoxemia, a condition in which the body does not receive enough oxygen. It is a non-invasive therapy that delivers oxygen directly to the airways and lungs through a mask or nasal cannula. The device is typically used in cases of chronic obstructive pulmonary disease (COPD), asthma, and other respiratory conditions. TOT is also used to treat acute respiratory distress syndrome (ARDS) and other acute respiratory conditions.
TOT is a relatively new technology, but it has been gaining popularity in recent years due to its effectiveness and ease of use. It is a safe and cost-effective alternative to traditional oxygen therapy, and it can be used in both hospital and home settings.
Some of the major companies in the TOT market include Philips Respironics, ResMed, Fisher & Paykel, and Invacare. These companies offer a variety of TOT devices, including masks, nasal cannulas, and oxygen concentrators. Show Less Read more